Applied UV Announces Pricing of $6.4 Million Upsized Underwritten Public Offering
November 14 2023 - 9:32AM
via NewMediaWire -- Applied UV, Inc. (Nasdaq: AUVI; AUVIP)
(“Applied UV” or the “Company”), a global leading provider of
advanced food security and air and surface disinfection technology,
today announced the pricing of a firm commitment underwritten
public offering with gross proceeds to the Company expected to be
approximately $6.4 million, before deducting underwriting discounts
and other estimated expenses payable by the Company. The offering
was upsized from $6.0 million. The base offering consists of
42,666,666 units or pre-funded units (the “Units”), each Unit
consisting of one share of common stock (“Common Stock”) or one
pre-funded warrant (“Pre-Funded Warrant”) to purchase one share of
Common Stock, one-tenth (1/10) of a Series A warrant (“Series A
Warrant”) to purchase one a share of Common Stock and one-tenth
(1/10) of a Series B Warrant to purchase one a share of Common
Stock (“Series B Warrant” and, together with the Series A Warrant,
the “Warrants”), at an offering price of $0.15 per Unit. The
purchase price of each Unit including a Pre-Funded Warrant will be
equal to the price per Unit including one share of Common Stock,
minus $0.00001, and the remaining exercise price of each Pre-Funded
Warrant will equal $0.00001 per share. The Pre-Funded Warrants will
be immediately exercisable and may be exercised at any time until
all of the Pre-Funded Warrants are exercised in full. The Company
intends to use the net proceeds to us from this offering for the
repayment of notes, and for general corporate purposes, including
working capital.
In addition, the Company has granted Aegis Capital Corp. a
45-day option to purchase additional shares of Common Stock and/or
Pre-Funded Warrants, representing up to 15% of the number of Common
Stock and/or Pre-Funded Warrants sold in the offering, and
additional Warrants representing up to 15% of the Warrants sold in
the offering, solely to cover over-allotments, if any.
The offering is expected to close on November 16, 2023, subject
to the satisfaction of customary closing conditions.
Aegis Capital Corp. is acting as the sole book-running
manager for the Offering
The offering was made pursuant to an effective registration
statement on Form S-1 (No. 333-274879) previously filed with the
U.S. Securities and Exchange Commission (the “SEC”) and declared
effective by the SEC on November 13, 2023. A preliminary prospectus
(the “Preliminary Prospectus”) describing the terms of the proposed
offering was filed with the SEC and is available on the SEC’s
website located at www.sec.gov. Electronic copies of the
Preliminary Prospectus may be obtained by contacting Aegis Capital
Corp., Attention: Syndicate Department, 1345 Avenue of the
Americas, 27th floor, New York, NY 10105, by email at
syndicate@aegiscap.com, or by telephone at (212) 813-1010. Before
investing in this offering, interested parties should read in their
entirety the registration statement and the Preliminary Prospectus
and the other documents that the Company has filed with the SEC
that are incorporated by reference in such registration statement
and the Preliminary Prospectus, which provide more information
about the Company and the offering.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Applied UV
Applied UV, Inc. provides proprietary surface and air pathogen
elimination and disinfection technology focused on improving indoor
air quality, specialty LED lighting and luxury mirrors and
commercial furnishings, all of which serve clients globally in both
the commercial and retail segments. For information on Applied UV,
Inc., and its subsidiaries, please visit www.applieduvinc.com.
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the closing
of the offering. Forward‐looking statements are based on the
Company’s current expectations and assumptions regarding its
business, the economy, and other future conditions. In this news
release, such forward-looking statements include statements
regarding the anticipated use of proceeds from the offering.
Because forward–looking statements relate to the future, they are
subject to inherent uncertainties, risks, and changes in
circumstances that are difficult to predict, many of which are
beyond the control of the Company, including those set forth in the
Risk Factors section of the Preliminary Prospectus. The Company’s
actual results may differ materially from those contemplated by the
forward‐looking statements. They are neither statements of
historical fact nor guarantees of assurance of future performance.
We caution you therefore against relying on any of these
forward‐looking statements. Factors or events that could cause the
Company’s actual results to differ may emerge from time to time,
and it is not possible for the Company to predict all of them. The
Company cannot guarantee future results, levels of activity,
performance, or achievements. Except as required by applicable law,
including the securities laws of the United States, the Company
does not intend to update any of the forward‐looking statements.
References and links to websites have been provided as a
convenience, and the information contained on such websites is not
incorporated by reference into this press release.
For additional Company Information:
Applied UV Inc.
Max Munn
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Oct 2024 to Nov 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Nov 2023 to Nov 2024